GlassScriptPhysician profile
Anais B Cortes
NPI 1750338364
$4,998.76
in general payments reported to CMS, 2019-2025
12 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $209 · 2021: $590 · 2022: $325 · 2023: $1,324 · 2024: $1,946 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,044 · Food and Beverage: $1,378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,043.65 |
| Food and Beverage | $1,377.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,889.64 | 2019-2024 | |
| Medtronic, INC. | $1,216.29 | 2021-2024 | Micra, Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan |
| Merck Sharp & Dohme LLC | $1,047.96 | 2023 | |
| Medtronic Vascular, INC. | $442.41 | 2019-2020 | |
| Coloplast Corp | $151.26 | 2025 | |
| Janssen Pharmaceuticals, INC | $140.39 | 2019-2021 | |
| Glaxosmithkline, LLC. | $35.14 | 2021-2022 | |
| Pfizer INC. | $18.11 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $17.65 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.24 | 2022 | |
| Allergan, INC. | $14.17 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.50 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anais Cortes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.